Beekmans, N.
Klemt-Kropp, M.
Funding for this research was provided by:
Gilead Sciences (IN-NL-174-2008)
Article History
Received: 6 September 2017
Accepted: 24 January 2018
First Online: 31 January 2018
Ethics approval and consent to participate
: The Northern Holland Hepatitis Retrieval Project was approved by the local ethics committee.
: Not applicable
: N. Beekmans has received research funding from Gilead Sciences. M. Klemt-Kropp has served as a speaker, a consultant and advisory board member for AbbVie, Roche and Janssen, and has received research funding from Gilead Sciences.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.